| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000048527 |
| Receipt No. | R000055295 |
| Scientific Title | Juntendo oral hypofunction registration of exploring for predictors and prognosis in Elderly in Tokyo. |
| Date of disclosure of the study information | 2022/08/01 |
| Last modified on | 2022/07/31 (Ver. 1) |
| Basic information | ||
| Public title | Juntendo oral hypofunction registration of exploring for predictors and prognosis in Elderly in Tokyo. | |
| Acronym | Juntendo oral hypofunction registration of exploring for predictors and prognosis in Elderly in Tokyo. | |
| Scientific Title | Juntendo oral hypofunction registration of exploring for predictors and prognosis in Elderly in Tokyo. | |
| Scientific Title:Acronym | Juntendo oral hypofunction registration of exploring for predictors and prognosis in Elderly in Tokyo. | |
| Region |
|
|
| Condition | ||||||||
| Condition | Sarcopenia, frailty | |||||||
| Classification by specialty |
|
|||||||
| Classification by malignancy | Others | |||||||
| Genomic information | NO | |||||||
| Objectives | |
| Narrative objectives1 | To extend healthy life expectancy by investigating the actual situation of oral frailty, which is one of the causes of falls and decreased mental and social activity level due to low nutrition, and to study countermeasure methods to reduce the risk to nursing care needs.
|
| Basic objectives2 | Others |
| Basic objectives -Others | The purpose of this study is to investigate the frequency and predictors of oral hypofunction and frailty and sarcopenia in outpatients aged 65 years and older at our medical center, and to further investigate the prognosis of oral hypofunction and factors that worsen prognosis. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Incidence of all-cause mortality and hospitalization for treatment at 1 and 2 years after the start of enrollment, respectively, according to the presence of oral hypofunction and frailty/sarcopenia |
| Key secondary outcomes | Incidence of major bleeding, clinically significant non-major bleeding, cardiovascular death, hospitalization for heart failure, nonfatal myocardial infarction, coronary revascularization, peripheral vascular disease, intracranial bleeding, stroke, transient ischemic attack, new onset of cancer, number of falls, fractures, gastrointestinal bleeding, hospitalization for pneumonia, increased dose of dementia medication, depending on presence of oral hypofunction and frailty/sarcopenia |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 Regular outpatient at Juntendo Tokyo Koto Medical Center for the Elderly, Juntendo University School of Medicine 2 Age 65 or older
3 Independent walking (including walking with a cane) 4 Patients with consent to participate in the study |
|||
| Key exclusion criteria | 1 Patients who are unable to walk independently or who are unable to take a medical history/questionnaire
2 Patients with serious cerebrovascular, cardiac, respiratory, hepatic, renal, gastrointestinal, or endocrine-metabolic diseases 3 Patients whose life expectancy is judged to be within 1 year due to malignant diseases 4 Patients deemed ineligible by the attending physician |
|||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University Graduate School of Medicine | ||||||
| Division name | Department of Respiratory Medicine | ||||||
| Zip code | 136-0075 | ||||||
| Address | 3-3-20, Shinsuna, Koto-ku, Tokyo | ||||||
| TEL | 03-5632-3111 | ||||||
| kmatsuno@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University Graduate School of Medicine | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 136-0075 | ||||||
| Address | 3-3-20, Shinsuna, Koto-ku, Tokyo | ||||||
| TEL | 03-5632-3111 | ||||||
| Homepage URL | |||||||
| daisuke@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Juntendo Tokyo Koto Geriatric Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Juntendo Tokyo Koto Geriatric Medical Center Ethics Committee |
| Address | 3-3-20 Shinsuna, Koto-ku, Tokyo |
| Tel | 03-5632-3111 |
| kmatsuno@juntendo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | observational study
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055295 |